First Nine-Month Complete Invasive Assessment (Angiography, IVUS, and OCT) of the Novel NEVO™ Sirolimus-Eluting Stent With Biodegradable Polymer

被引：6

作者：

Abizaid, Alexandre ^{[1
]}

Ribamar Costa, J., Jr. ^{[1
]}

Feres, Fausto ^{[1
]}

机构：

[1] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil

来源：

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS | 2011年 / 77卷 / 01期

关键词：

percutaneous coronary intervention (PCI); angiography-coronary (ANGO); intravascular ultrasound (IVUS);

D O I：

10.1002/ccd.22558

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

At present, percutaneous coronary intervention with drug-eluting stent (DES) implantation represents the default strategy to treat coronary artery disease in many institutions around the world. However, concerns regarding long-term safety of first-generation DES have prompted the development of novel DES systems such as the NEVO (TM) (Cordis Corporation, Johnson & Johnson, Warren, NJ) sirolimus-eluting stent with biodegradable polymer and reservoir technology. In the current report, we present, for the first time, a complete midterm invasive assessment of a patient treated with this novel device in the Res-Elution I study. (C) 2010 Wiley-Liss, Inc.

引用

页码：49 / 51

页数：3